Dr. Isabelle Boileau is a senior scientist and the Associate Director of the Brain Health Imaging Centre and Head of the Addiction Imaging Research Group at the Centre for Addiction and Mental Health (CAMH). She is an associate professor of Psychiatry and of Pharmacology and Toxicology and a member of the Institute of Medical Science at the University of Toronto.
Areas of Research
Dr. Isabelle Boileau’s lab focuses on the use of translational imaging approaches (i.e.: positron emission tomography imaging (PET) and magnetic resonance imaging (MRI)) to help test novel, targetable mechanisms of neuropsychiatric disorders, specifically addictions and trauma –related conditions. As Canada Research Chair in Endocannabinoid Imaging, part of her research program actively investigates the role of the endocannabinoid system in mental health.
View Dr. Boileau's publications on PubMed.